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Consistency modeling for gene selection is a new 
topic emerging from recent cancer bioinformatics 
research. The result of classification or clustering on a 
training set was often found very different from the 
same operations on a testing set. Here, we address this 
issue as a consistency problem. We propose a new 
concept of performance-based consistency and a new 
novel gene selection method, Genetic Algorithm Gene 
Selection method in terms of consistency (GAGSc). 
The proposed consistency concept and GAGSc 
method were investigated on eight benchmark 
microarray and proteomic datasets. The experimental 
results show that the different microarray datasets 
have different consistency characteristics, and that 
better consistency can lead to an unbiased and 
reproducible outcome with good disease prediction 
accuracy. More importantly, GAGSc has demonstrated 
that gene selection, with the proposed consistency 
measurement, is able to enhance the reproducibility in 





The advent of microarray technology has made it 
possible to monitor the expression levels for thousands 
of genes simultaneously, which can help clinical 
decision making in complex disease diagnosis and 
prognosis, especially for cancer classification. A major 
challenge with microarray research is how to find 
informative genes that can be used for successfully 
discriminating variables in relation to different 
conditions, such as healthy and diseased. In a typical 
microarray dataset, the number of genes normally far 
exceeds that of samples. For example, there are 78 
samples vs. 24,482 genes in the breast cancer dataset 
of [1]. Furthermore, those genes usually include many 
redundant genes that can confuse a classifying 
algorithm. Therefore, selecting informative genes from 
a dataset is a fundamental task for microarray research. 
The reliability of microarray data analysis has been 
disputed in recent scientific literature, because many 
impressive results of microarray experiments could not 
be reproduced. In our previous experiments, the results 
obtained from the operations, such as classification and 
clustering on the training set were often found very 
different from the results of the same operations on the 
testing set. For example, the training set from CNS 
cancer data [2] can get a performance of above 90% 
true positive (TP) accuracy for tumour classification, 
whereas the testing data only gets 70% of TP accuracy. 
This occurs, because the typical methods for gene 
selection use only a single criterion of distance 
measurement between patients and non-patients, and 
disregard consistency between the subsets of data with 
the selected genes.  
This issue is here discussed, which is referred to the 
consistency problem. Moreover, it is also noticed in 
our experiments that selecting a set of proper genes 
can significantly reduce the inconsistency of 
microarray data experiment. Obviously, it is more 
interesting to discover a set of genes that enable a 
consistently good classification performance over 
different subsets of patients in the complete microarray 
data. 
The remainder of this paper is structured as follows. 
Section 2 services to briefly review the related work on 
consistency concept, following the description of our 
proposed consistency concept and GAGSc method. In 
section 3, the experiment setup and results are 
provided. The final section presents discussions and 
conclusions.   
 
2. Consistency concept and GAGSc method 
2.1. Related work 
Probabilistic consistency analysis for gene selection 
method [3] is a recent novel approach that focuses on 
analyzing the common genes selected from two 
datasets. Consistency in this method is defined as 
follows: 
Suppose two microarray datasets Da and Db 
targeting the same bioinformatics task, each having 
same number of genes. r is a ranking function 
generating two lists of sorted genes from the two 
datasets. Let s top-ranked genes in each case be 
selected and denoted by Sa and Sb. Then, the 
consistency C of this dataset is given by: 
 C(r, s, Da,Db) = | Sa ∩ Sb |  (1) 
Consistency C is thus the number of genes in 
common between two datasets, and depends on 
ranking function, data and the number of selected 
genes [3].  
Mukherjee and his colleagues have applied this 
probabilistic consistency to their data-adaptive (DA) 
gene selection method. In their gene selection process, 
the result of probabilistic consistency obtained from 
top-selected genes is used for optimizing the test 
statistics function. After hundreds of iterations, an 
optimized statistic function can be achieved based on 
consistency. 
However, it is not clear to what extent the selected 
informative are related to the consistency of final 
classification performance, i.e. the performance of 
classification over individual sampling subsets of a 
complete dataset may still have a very inconsistent 
result, even though the common-gene method is 
employed. 
 
2.2 Proposed consistency concept and GAGSc 
method 
 
The idea of our approach is using the result of 
consistency obtained from an operation (e.g. 
classification, clustering, etc.) to find informative 
genes for a microarray dataset. For most microarray 
datasets, there tends to be no agreement on which 
genes are highly differentially expressed, and 
consequently it is difficult to measure the reliability of 
any gene selection method. In practice, the 
performance of an operation over microarray data is a 
straightforward criterion for measuring the outcomes 
of microarray experiments. Our new solution is based 
on optimizing computation which takes consistency 
into account. 
The definition of our proposed consistency concept 
is as follows: 
Consider a dataset pertaining to a bioinformatics 
task (two classes) and denoted by D. The dataset D 
consists of n samples with m genes, and all samples 
belong to two classes (e.g. class 1 or class 2). Da and 
Db are two subsets of D obtained by random 
subsampling, and serve as training and testing datasets, 
respectively. 
  a b a bD = D   D  &  D   D  = ∅∪ ∩      (1) 
Given a base function F over D, and a gene 
selection function fs over Da, the consistency of dataset 
D can be calculated as  
 C(F, fs, D) = | Pa - Pb | (2) 
where Pa and Pb are the outcome of the function F on 
Da and Db, 
 Pi = F( fs(D), Di) | i = a, b. (3) 
Base function F can be any of various data 
processing models, such as clustering function, feature 
extraction function, classification function, etc., it 
determines the feature space on which the consistency 
is based on. In the concept of consistency based on 
performance, F is set as one type of classification 
function. 
As F is assigned as a classification function, the 
above fundamental consistency definition Eq. (2) can 
be extended as a definition of consistency in terms of 
classification performance, 
 C(F,fs,D) = |F(fs(D),Da,Db)-F(fs(D),Db,Da)| (4) 
where fs(D) specifies D as the dataset for gene 
selection. Da in the first term of Eq.(4) is assigned for 
classifier training, and Db is for testing. The second 
term of Eq. (4) specifies a reversed training and testing 
position for Da and Db , respectively.  
The key idea of Genetic Algorithm Gene Selection 
method in terms of Consistency (GAGSc) proposed in 
this work is using the result of consistency in terms of 
performance obtained from an operation (e.g. 
classification or clustering) to find a small set of 
informative genes for a microarray dataset. 
Meanwhile, an evolutionary function is employed for 
selecting candidate genes. Two genetic operators, 
mutation and crossover are applied to this evolutionary 
function for optimizing the gene selection function.  
Given a dataset D, a list of genes S, and an 
operation function Fsc (e.g.classification), the 
optimized function performing GA method is expected 
to achieve: 








                     (5) 
where F refers to a family of evolutionary gene 
selection functions, Fsc and fs refer to the function of 
computing consistency under the condition of gene 
selection and gene selection function, respectively. 
 
The GAGSc algorithm can be simply summarized into 
the following steps: 
1.  Split all genes of dataset D into ρ segments based 
on their mean value (note that ρ is a pre-specified 
number). 
2. Randomly select one gene from each of ρ 
segments, respectively to form the initial candidate 
 gene set that is denoted by S. 
3.  Apply the operation function Fsc to the dataset 
containing those genes listed in S, and compute the 
consistency C by Eq. (4).  
4.  Perform gene selection function fs on S to get a 
new generation of genes S', and compute the 
consistency C'. 
5.  If C' > C, then C = C' and S = S'. 
6.  Repeat Steps 3-5 for N generations. N is a given 
number (usually >= 200) for determining how 
many generations are used in this case. 
7.  Output the finally selected genes. 
The optimized gene selection method is obtained after 







The proposed GAGSc method for selecting 
informative genes is applied to seven well-known 
benchmark cancer microarray datasets and one 
proteomics dataset. Table 1 summarizes the eight 
datasets used for gene selection in our experiment.  
 
3.2. Unbiased verification policy 
 
In most previous microarray data analysis work, 
sampling method is employed mainly for classification 
procedure, but not for gene selection procedure. Such 
methods produce the classification results eventually 
with bias, because the informative genes are selected 
from the whole dataset and not well estimated in terms 
of the generalization error. In practice, testing data is 
blind in real biology experiment, thus should not be 
allowed to be included in either gene selection or 
classification modelling. Therefore, the bias occurring 
in gene selection may finally result in an unreplicable 
disease diagnosis performance. 
A totally unbiased verification policy for microarray 
analysis should guarantee that no generalization error 
occurs in either gene selection or classification 
procedures. To this end, efficient data sampling 
method should be used in the two procedures to 
maximally decrease the generalization error. In other 
words, the classification also needs to employ the 
verification methods to estimate the bias error. In our 
gene selection experiment, we utilized such a totally 
unbiased verification scheme in which the 
classification accuracy is obtained from an 




For clarity, the classification accuracies obtained by 
GAGSc method is summarized in Table 2, and the 
reported accuracies in the papers listed in Table 1 is 
added as well. Our proposed GAGSc method 
outperforms the published methods on four datasets, 
and the classification result on colon data is very close 
to the reported accuracy. However, the classification 
accuracies of three datasets (CNS, Breast and 
Esophageal) are significantly lower than the published. 
As discussed in introduction, many published 
classification results are not based on efficient 
validation schemes, which results in the experiments 
are unreplicable and too optimistic. However, the 
experimental results obtained by the proposed GAGSc 
method can be easily reproduced, because the totally 
unbiased validation scheme is applied in this study. 
These results suggest that reproducible prognosis is 
possible for only 4 or 5 of the 8 used benchmark 
datasets in Table 2. 
Table 1. Summary of microarray and proteomics datasets used for experiments 
Data name Class 1 vs. Class 2 Number Training Samples of Genes (class 1/2) 
Validation 
Samples Ref. 
Lymphoma Diffused large B cell lymphoma vs. other types 4026 (42/54) 96 - [4] 
Leukaemia ALL vs. AML 7129 (27/11) 38 34 [5]
CNS tumour Survivor vs. Failure 7129 (21/39) 60 - [2]
Colon Cancer Normal vs. Tumour 2000 (22/40) 62 - [6]
Ovarian Cancer vs. Normal 15154 (91/162) 253 - [7]
Breast Cancer Relapse vs. Non-Relapse 24482 (34/44) 78 19 [1]
Lung Cancer MPM vs. ADCA 12533 (16/16) 32 149 [8]
Esophageal Cancer  Non-responder vs. Responder 859 (15/12)27 15 [9]
Table 2. Classification accuracy comparison: 
GAGSc results vs. known results from literature 
(See Refs in Table 1.) 
Classification accuracy Data 
GAGSc Publication
Lymphoma 95.84% 72.5%
Leukaemia 94.12% 85% 
CNS Tumour 65.00% 83% 
Colon Cancer 83.81% 87% 
Ovarian 98.80% 97% 
Breast Cancer 63.16% 94% 
Lung Cancer 91.28% 90% 
Esophageal Cancer  46.67% 93.3% 
 
In our experiments, all data for validation is 
independent and never touched in the training process. 
Therefore, the selected informative genes are entirely 
fair to any given data for validation. Such a mechanism 
of gene selection might result in the bad performance 
in certain microarray datasets, which is due to their 
characteristics. However, the reported good results in 
published papers of these datasets are suspect.  
The proposed GAGSc method has demonstrated that 
the consistency concept can be used for gene selection 
to solve the reproducibility problem in microarray data 
analysis. The main contribution of proposed GAGSc 
gene selection method is that it ensures the reliability 
and reproducibility of microarray data analysis 
experiments, and improves the disease classification 
performance as well. 
According to our experimental results, we found that 
the classification performance could not be improved 
significantly after 200 generations. In general, using 
20~30 (ρ) initially selected genes could produce the 
best and repeatable results.  
 
4. Discussion and conclusions 
 
We have briefly described a new gene selection 
method (GAGSc) in the proposed performance-based 
consistency theory. The main contributions of this 
study are: (1) The proposed consistency concept can be 
easily incorporated into more sophisticated gene 
selection systems to enhance the overall performance 
of microarray data analysis; (2) Using the proposed 
GAGSc method, the final selected informative genes 
can construct a better classifier for disease diagnosis in 
terms of prediction accuracies. The unbiased 
prediction accuracies on eight benchmark datasets 
obtained by GAGSc method in this study are very 
competitive to the reported results in literature. Note 
that some published prediction results are not validated 
on independent datasets, and thus remain suspect. 
The findings of this study indicate that the proposed 
consistency concept in gene selection is a useful 
innovation in several areas. To further improve the 
gene selection methods based on the proposed 
consistency concept, it would be interesting to 
incorporate clustering in the pre-process stage of gene 
selection.  
The huge computational complexity is one of the 
main limitations of the proposed GAGSc method. To 
alleviate computational complexity, cluster algorithms 
are intended to be used before GA search to find a 
certain number of clusters.  Then these clusters can be 
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